TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system
Stefan Bittner(Johannes Gutenberg University Mainz), Heinz Wiendl(University Medical Center Freiburg)
Cited by 105
Related Papers
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706
Ofatumumab versus Teriflunomide in Multiple Sclerosis
|New England Journal of Medicine|2020|706
How patients with multiple sclerosis acquire disability
|Brain|2022|532
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
|CNS Drugs|2014|293